Scientists provided compelling evidence attesting to the reliability and potential of patient-derived xenograft (PDX)and PDX-derived organoid models in the realm of precision medicine. These models were instrumental in identifying patients who were likely to respond favorably to a specific drug treatment.
[Clinical and Translational Oncology]

Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News